Newsroom

Featured

Featured

Former Editor of The Economist joins Airfinity as advisor

story

Former Editor of The Economist joins Airfinity as advisor

Published by Airfinity

Jan 17, 2023

China to see one longer, more severe COVID wave as Lunar Festival fuels outbreak

story

China to see one longer, more severe COVID wave as Lunar Festival fuels outbreak

Published by Airfinity

Jan 17, 2023

Airfinity CEO Says Covid Peak Could Go Much Higher

press

Airfinity CEO Says Covid Peak Could Go Much Higher

Published by Bloomberg TV

Dec 12, 2022

China’s ‘zero-COVID’ limits saved lives but no clear exit

press

China’s ‘zero-COVID’ limits saved lives but no clear exit

Published by Associated Press

Nov 28, 2022

Without a nasal vaccine, the U.S. edge in fighting Covid is on the line

press

Without a nasal vaccine, the U.S. edge in fighting Covid is on the line

Published by Politico

Oct 15, 2022

Introducing Airfinity Biorisk: Risk Surveillance and Analytics for 160+ Infectious Diseases

story

Introducing Airfinity Biorisk: Risk Surveillance and Analytics for 160+ Infectious Diseases

Published by Airfinity

Oct 10, 2022

AstraZeneca’s infant RSV drug Beyfortus could generate $1.1bn sales revenue

story

AstraZeneca’s infant RSV drug Beyfortus could generate $1.1bn sales revenue

Published by Airfinity

Sep 16, 2022

18 million monkeypox vaccines needed to protect most at risk, 85 million to protect wider gay community and health workers

story

18 million monkeypox vaccines needed to protect most at risk, 85 million to protect wider gay community and health workers

Published by Airfinity

Aug 25, 2022

AstraZeneca and Pfizer/BioNTech saved over 12 million lives in the first year of vaccination

story

AstraZeneca and Pfizer/BioNTech saved over 12 million lives in the first year of vaccination

Published by Airfinity

Jul 13, 2022